Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Published in: Journal of Neuro-Oncology 3/2016

01-09-2016 | Letter to the Editor

Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg)

Authors: Chi Tung Choy, Chi Hang Wong, Herbert Ho Fung Loong

Published in: Journal of Neuro-Oncology | Issue 3/2016

Login to get access

Excerpt

To the Editor, …
Literature
1.
Khoury O, Ghazale N, Stone E, El-Sibai M, Frankel AE, Abi-Habib RJ (2015) Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. J Neurooncol 122(1):75–85. doi:10.​1007/​s11060-014-1698-5 CrossRefPubMed
2.
Lam TL, Wong GK, Chong HC, Cheng PN, Choi SC, Chow TL, Kwok SY, Poon RT, Wheatley DN, Lo WH, Leung YC (2009) Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest. Cancer Lett 277(1):91–100. doi:10.​1016/​j.​canlet.​2008.​11.​031 CrossRefPubMed
3.
Fiedler T, Strauss M, Hering S, Redanz U, William D, Rosche Y, Classen CF, Kreikemeyer B, Linnebacher M, Maletzki C (2015) Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo. Cancer Biol Ther 16(7):1047–1055. doi:10.​1080/​15384047.​2015.​1026478 CrossRefPubMedPubMedCentral
Metadata
Title
Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg)
Authors
Chi Tung Choy
Chi Hang Wong
Herbert Ho Fung Loong
Publication date
01-09-2016
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-016-2209-7

Other articles of this Issue 3/2016

Journal of Neuro-Oncology 3/2016 Go to the issue

Laboratory Investigation

Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors

Clinical Study

Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors

Clinical Study

The clinical significance of fascin expression in a newly diagnosed primary glioblastoma

Clinical Study

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis

Letter to the Editor

Coexistence of MLH3 germline variants in colon cancer patients belonging to families with Lynch syndrome-associated brain tumors

Clinical Study

The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma